Regeneron Acquisitions

Regeneron has acquired 4 companies and its latest acquisition was Oxular Limited on Jan 2025

COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION
Oxular Limited

Jan 2025

Source »
undisclosed
Oxular is an England-based biotechnology company that discovers and develops novel drugs for the treatment of retinal diseases.

-

2seventy Bio’s Preclinical and Clinical Stage Cell Therapy Pipeline

Jan 2024

Source »
$5M
-
Decibel Therapeutics, Inc.

Aug 2023

Source »
$109M
Decibel Therapeutics is a Massachusetts-based biotechnology company that researches and develops drugs for the treatment of ear, nose, and throat diseases.
Checkmate Pharmaceuticals, Inc.

Apr 2022

Source »
$250M
Checkmate Pharmaceuticals is a Massachusetts-based biopharmaceutical company that develops and commercializes immunotherapies for the treatment of cancer.

Frequently Asked Questions about Regeneron

  1. What companies did Regeneron acquire?

    Companies acquired by Regeneron include Oxular, and Decibel
  2. How many acquisitions does Regeneron have?

    Regeneron has acquired 4 companies including Oxular, and Decibel.
  1. How many acquisitions did Regeneron make in 2025?

    In 2025 Regeneron acquired 1 companies including Oxular.